Sana Biotechnology picks up $700m in VC financing

Sana Biotechnology, a Seattle, Washington-based company focused on creating and delivering engineered cells as medicines, has raised more than US$700 million.

DealsCanadaNorth AmericaUSHealthcareBriefs